FATE THERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.885 USD | -0.38% |
|
-6.58% | +3.66% |
| May. 10 | Piper Sandler Adjusts Fate Therapeutics' Price Target to $4 From $7, Keeps Neutral Rating | MT |
| May. 10 | Wedbush Adjusts Fate Therapeutics' Price Target to $5 From $7, Keeps Neutral Rating | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-14 | 2024-05-15 | 2024-05-16 | 2024-05-17 | 2024-05-20 | |
|---|---|---|---|---|---|
| Last | 4.22 $ | 4.24 $ | 4.14 $ | 3.9 $ | 3.885 $ |
| Volume | 2 483 361 | 1 895 572 | 1 589 577 | 1 342 024 | 809 379 |
| Change | +1.69% | +0.47% | -2.36% | -5.80% | -0.38% |
| Opening | 4.18 | 4.38 | 4.26 | 4.18 | 3.91 |
| High | 4.39 | 4.50 | 4.30 | 4.18 | 4 |
| Low | 4.08 | 4.18 | 4.03 | 3.87 | 3.805 |
Performance
| 1 day | -6.02% | ||
| 1 week | -4.41% | ||
| Current month | -1.27% | ||
| 1 month | -18.58% | ||
| 3 months | -48.41% | ||
| 6 months | +60.49% | ||
| Current year | +4.28% | ||
| 1 year | -21.69% | ||
| 3 years | -94.82% | ||
| 5 years | -79.19% | ||
| 10 years | -40.91% |
Volumes
marketsDaily volume
1 342 024
Estimated daily volume
1 342 024
Avg. Volume 20 sessions
3 012 116
Daily volume ratio
0.45
Avg. Volume 20 sessions USD
11 747 252.40
Record volume 1
33 570 120
Record volume 2
17 640 779
Record volume 3
17 427 290
Capital turnover ratio
0.03
Float rotation
0.03
Basic data
Capitalization (USD)
443 944 679
Net sales (USD)
63 533 000
Number of employees
181
Sales / Employee (USD)
351 011
Free-Float
98.42 %
Free-Float capitalization (USD)
436 927 592
Average Daily Capital Traded
2.65%
Highs and lows
1 week
3.87
4.50
1 month
3.585.02
Current year
3.468.83
1 year
1.638.83
3 years
1.6397.43
5 years
1.63121.16
10 years
1.46121.16
Indicators
Moving average 5 days
4.13
Moving average 20 days
4.14
Moving average 50 days
5.77
Moving average 100 days
5.67
Price spread / (MMA5)
+5.95%
Price spread / (MMA20)
+6.24%
Price spread / (MMA50)
+48.06%
Price spread / (MMA100)
+45.37%
STIM
RSI 9 days
43.21
RSI 14 days
38.39
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -6.02% | -4.41% | +4.28% | -21.69% | 444M | ||
| +1.04% | +5.31% | +9.42% | +30.29% | 115B | ||
| +1.48% | +0.87% | +11.84% | +29.41% | 106B | ||
| -1.53% | -2.19% | -2.56% | -14.25% | 21.96B | ||
| -2.55% | -1.16% | -14.15% | -14.91% | 21.87B | ||
| +0.74% | +1.90% | -5.29% | -27.68% | 19.21B | ||
| +1.06% | +7.27% | -4.16% | -25.69% | 18.08B | ||
| -1.49% | +0.11% | -38.29% | -33.18% | 17.71B | ||
| +0.27% | +4.09% | +7.99% | +51.28% | 14.32B | ||
| -1.02% | -0.33% | +36.24% | -11.88% | 12.42B | ||
| -2.61% | +4.44% | -24.95% | -35.24% | 8.23B | ||
| -1.17% | +14.39% | +18.74% | +54.61% | 8.11B | ||
| -0.59% | -0.21% | -0.71% | +29.70% | 7.67B | ||
| -0.14% | -0.71% | -52.57% | -68.48% | 7.49B | ||
| -3.03% | -9.02% | +260.02% | +191.68% | 7.39B | ||
| -1.37% | -9.25% | -3.83% | +34.00% | 6.95B | ||
| Average | -1.06% | +0.29% | +12.63% | +10.50% | ||
| Weighted average by Cap. | +0.29% | +2.01% | +7.96% | +16.48% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
4f3cd173c4a9d.7HGjNjDRlJONVX5xRKYWWBXrjnLn4SqizOCl8p7PS8g.wQmOVFm-7treBgwjDOtiB2S7yCaO0G73_rPXp_WbP_-CQtl0Rav50f8DDQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 3.9 | 321,033 | 1,150,970 |
| 03:59:59 pm | 3.9 | 200 | 829,937 |
| 03:59:59 pm | 3.9 | 200 | 829,737 |
| 03:59:59 pm | 3.9 | 100 | 829,537 |
| 03:59:59 pm | 3.9 | 100 | 829,437 |
| 03:59:59 pm | 3.9 | 100 | 829,337 |
| 03:59:59 pm | 3.905 | 100 | 829,237 |
| 03:59:58 pm | 3.905 | 400 | 829,137 |
| 03:59:58 pm | 3.905 | 200 | 828,737 |
| 03:59:58 pm | 3.9 | 300 | 828,537 |
Monthly variations
Annual change
| 2024 | +4.28% | ||
| 2023 | -62.93% | ||
| 2022 | -82.76% | ||
| 2021 | -35.65% | ||
| 2020 | +364.64% | ||
| 2019 | +52.53% | ||
| 2018 | +109.98% | ||
| 2017 | +143.43% | ||
| 2016 | -25.52% | ||
| 2015 | -33.00% | ||
| 2014 | -19.90% | ||
| 2013 | -5.14% |
- Stock Market
- Equities
- FATE Stock
- Quotes Fate Therapeutics, Inc.
